While it was generally assumed that the return to power of business-friendly President Donald Trump would help facilitate M&A ...

Biogen’s CEO Chris Vibacher said ‘a new Biogen’ is emerging following the end of its multiple sclerosis treatments heyday.

Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.

The US State Department has approved a potential $131m foreign military sale of Indo-Pacific Maritime Domain Awareness (IPMDA ...

Artificial Intelligence (AI) often knows us better than we know ourselves, which makes it handy for quick, comprehensive ...

Eurazeo has acquired the remaining shares in Kurma Partners, an asset management company specializing in biotechnology and ...

GlobalData is a data, insights and analytics platform. GlobalData has confirmed it has received preliminary, conditional takeover proposals from both ICG and KKR, following recent media speculation.

Here's a list of the companies that have announced new U.S. investments since Trump took office: Merck on Tuesday said it is ...

Britain's GlobalData said on Wednesday it had received preliminary takeover proposals from funds managed by private equity ...

Biopharma venture funding dropped 20% in the first quarter of 2025 compared to the same period the year before, according to ...

The persistent concerns about U.S. valuations stem not from imminent recession fears but from long-term impacts of populist ...

GlobalData said it received takeover proposals from Kohlberg Kravis Roberts & Co. and ICG Europe Fund IX SCSP. The data, analytics and insights platform said Wednesday that it is in preliminary talks ...